(Q52426105)

1 May 2018

title

Carboplatin and etoposide pharmacokinetics in patients with testicular teratoma. (English)

1 reference

1 May 2018

1 reference

1 reference

1 reference

2

1 reference

1 May 2018

author name string

D R Newell

1

1 reference

1 May 2018

L A Gumbrell

3

1 reference

1 May 2018

F E Boxall

4

1 reference

1 May 2018

A Horwich

5

1 reference

1 May 2018

A H Calvert

6

1 reference

1 May 2018

language of work or name

English

0 references

publication date

1 January 1989

1 reference

1 May 2018

Cancer Chemotherapy and Pharmacology

published in

1 reference

1 May 2018

volume

23

1 reference

1 May 2018

issue

6

1 reference

1 May 2018

page(s)

367-372

1 reference

1 May 2018

https://scigraph.springernature.com/pub.10.1007/bf00435838

exact match

0 references

cites work

Phase I clinical trial and pharmacokinetics of carboplatin (NSC 241240) by single monthly 30-minute infusion

1 reference

12 December 2020

Normalization in the fitting of data by iterative methods. Application to tracer kinetics and enzyme kinetics

1 reference

12 December 2020

Clinical pharmacology of high-dose etoposide associated with cisplatin. Pharmacokinetic and metabolic studies

1 reference

12 December 2020

Pharmacokinetics of carboplatin after i.v. administration

1 reference

12 December 2020

Hypomagnesemia, renal dysfunction, and Raynaud's phenomenon in patients treated with cisplatin, vinblastine, and bleomycin

1 reference

12 December 2020

Iproplatin and carboplatin induced toxicities: overview of phase II clinical trial conducted by the EORTC Early Clinical Trials Cooperative Group (ECTG).

1 reference

12 December 2020

Pharmacokinetics of cis-diammine-1,1-cyclobutane dicarboxylate platinum(II) in patients with normal and impaired renal function

1 reference

12 December 2020

Cisplatin neuropathy. Clinical, electrophysiologic, morphologic, and toxicologic studies.

1 reference

12 December 2020

Plasma free platinum pharmacokinetics in patients treated with high dose carboplatin

1 reference

12 December 2020

Results of NCI-sponsored phase I trials with carboplatin

1 reference

12 December 2020

Glomerular filtration rate measurement in man by the single injection methods using 51Cr-EDTA

1 reference

12 December 2020

Early clinical studies with cis-diammine-1,1-cyclobutane dicarboxylate platinum II.

1 reference

12 December 2020

Phase I clinical and pharmacologic trial of carboplatin daily for 5 days

1 reference

12 December 2020

Effect of human renal and hepatic disease on the pharmacokinetics of anticancer drugs

1 reference

12 December 2020

Pharmacokinetics of etoposide (VP16) in children and adolescents with refractory solid tumors

1 reference

12 December 2020

Pharmacokinetics of etoposide in patients with abnormal renal and hepatic function

1 reference

12 December 2020

Pharmacokinetics of unchanged carboplatin (CBDCA) in patients with small cell lung carcinoma

1 reference

12 December 2020

Assessment of Pharmacokinetic Constants from Postinfusion Blood Curves Obtained after I.V. Infusion

1 reference

12 December 2020

cis-Diammine-1, 1-cyclobutane dicarboxylate platinum II (carboplatin) in the treatment of testicular germ-cell tumours: a preliminary report.

1 reference

12 December 2020

Drug monitoring of etoposide (VP16-213). Correlation of pharmacokinetic parameters to clinical and biochemical data from patients receiving etoposide

1 reference

12 December 2020

Pharmacokinetics and dosage reduction of cis-diammine(1,1-cyclobutanedicarboxylato)platinum in patients with impaired renal function

1 reference

12 December 2020

A phase I and pharmacokinetic study of diamminecyclobutane-dicarboxylatoplatinum (NSC 241240).

1 reference

12 December 2020

Etoposide pharmacokinetics in patients with normal and abnormal organ function

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00435838

1 reference

1 May 2018

PubMed ID

2469544

1 reference

1 May 2018